Assessing preparedness for Alzheimer disease-modifying therapies in Australasian health care systems

被引：8

作者：

Brodtmann, Amy ^{[1
,2
]}

Darby, David ^{[1
]}

Oboudiyat, Carly ^{[3
]}

Mahoney, Colin J. ^{[4
]}

Le Heron, Campbell ^{[5
]}

Panegyres, Peter K. ^{[6
]}

Brew, Bruce ^{[7
]}

机构：

[1] Monash Univ, Melbourne, Vic, Australia

[2] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia

[3] Royal North Shore Hosp, Sydney, NSW, Australia

[4] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia

[5] New Zealand Brain Res Inst, Christchurch, New Zealand

[6] Neurodegenerat Disorders Res, Perth, WA, Australia

[7] Univ New South Wales, Sydney, NSW, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2023年 / 218卷 / 06期

关键词：

Alzheimer disease; Dementia; Neurodegenerative disorders; Medical colleges; Health personnel; Magnetic resonance imaging;

D O I：

10.5694/mja2.51880

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：247 / 249

页数：3

共 21 条

[1] Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials [J].

Andrews, J. Scott ;

Desai, Urvi ;

Kirson, Noam Y. ;

Zichlin, Miriam L. ;

Ball, Daniel E. ;

Matthews, Brandy R. .

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) :354-363

[2] An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders [J].

Ashton, Nicholas J. ;

Hye, Abdul ;

Rajkumar, Anto P. ;

Leuzy, Antoine ;

Snowden, Stuart ;

Suarez-Calvet, Marc ;

Karikari, Thomas K. ;

Scholl, Michael ;

La Joie, Renaud ;

Rabinovici, Gil D. ;

Hoglund, Kina ;

Ballard, Clive ;

Hortobagyi, Tibor ;

Svenningsson, Per ;

Blennow, Kaj ;

Zetterberg, Henrik ;

Aarsland, Dag .

NATURE REVIEWS NEUROLOGY, 2020, 16 (05) :265-284

[3]

Australian Institute of Health and Welfare, 2022, DEM AUSTR

[4] Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010 [J].

Beach, Thomas G. ;

Monsell, Sarah E. ;

Phillips, Leslie E. ;

Kukull, Walter .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (04) :266-273

[5]

Cavazzoni P., 2021, FDA's Decision to Approve New Treatment for Alzheimer's Disease

[6]

Centers for Medicare and Medicaid Services, CMS FIN MED COV POL

[7] Aducanumab: Appropriate Use Recommendations Update [J].

Cummings, J. ;

Rabinovici, G. D. ;

Atri, A. ;

Aisen, P. ;

Apostolova, L. G. ;

Hendrix, S. ;

Sabbagh, M. ;

Selkoe, D. ;

Weiner, M. ;

Salloway, S. .

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2022, 9 (02) :221-230

[8] Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus A Report of the AAN Guidelines Subcommittee [J].

Day, Gregory S. ;

Scarmeas, Nikolaos ;

Dubinsky, Richard ;

Coerver, Katherine ;

Mostacero, Anitra ;

West, Brooks ;

Wessels, Scott R. ;

Armstrong, Melissa J. .

NEUROLOGY, 2022, 98 (15) :619-631

[9] Integrated care for adults with dementia and other cognitive disorders [J].

Draper, Brian ;

Low, Lee-Fay ;

Brodaty, Henry .

INTERNATIONAL REVIEW OF PSYCHIATRY, 2018, 30 (06) :272-291

[10] Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies A Systematic Review [J].

Filippi, Massimo ;

Cecchetti, Giordano ;

Spinelli, Edoardo Gioele ;

Vezzulli, Paolo ;

Falini, Andrea ;

Agosta, Federica .

JAMA NEUROLOGY, 2022, 79 (03) :291-304

← 1 2 3 →